Emergence of New Pandemic GII.4 Sydney Norovirus Strain Correlates With Escape From Herd Immunity
Author(s) -
Kari Debbink,
Lisa C. Lindesmith,
Eric Donaldson,
Verónica Costantini,
Martina Beltramello,
Davide Corti,
Jesica Swanstrom,
Antonio Lanzavecchia,
Jan Vinjé,
Ralph S. Baric
Publication year - 2013
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jit370
Subject(s) - virology , epitope , norovirus , neutralization , polyclonal antibodies , outbreak , biology , pandemic , monoclonal antibody , antigen , immunity , blockade , virus , antibody , microbiology and biotechnology , medicine , immunology , disease , immune system , covid-19 , genetics , infectious disease (medical specialty) , receptor , pathology
GII.4 noroviruses are a significant source of acute gastroenteritis worldwide, causing the majority of human norovirus outbreaks. Evolution of the GII.4 major capsid protein occurs rapidly, resulting in the emergence of new strains that produce successive waves of pandemic disease. A new pandemic isolate, GII.4 2012 Sydney, largely replaced previously circulating strains in late 2012. We compare the antigenic properties of GII.4 2012 Sydney with previously circulating strains.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom